These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

512 related items for PubMed ID: 20458576

  • 1. Changes in trabecular and cortical bone microarchitecture at peripheral sites associated with 18 months of teriparatide therapy in postmenopausal women with osteoporosis.
    Macdonald HM, Nishiyama KK, Hanley DA, Boyd SK.
    Osteoporos Int; 2011 Jan; 22(1):357-62. PubMed ID: 20458576
    [Abstract] [Full Text] [Related]

  • 2. Characterizing microarchitectural changes at the distal radius and tibia in postmenopausal women using HR-pQCT.
    Kawalilak CE, Johnston JD, Olszynski WP, Kontulainen SA.
    Osteoporos Int; 2014 Aug; 25(8):2057-66. PubMed ID: 24781379
    [Abstract] [Full Text] [Related]

  • 3. Postmenopausal women treated with combination parathyroid hormone (1-84) and ibandronate demonstrate different microstructural changes at the radius vs. tibia: the PTH and Ibandronate Combination Study (PICS).
    Schafer AL, Burghardt AJ, Sellmeyer DE, Palermo L, Shoback DM, Majumdar S, Black DM.
    Osteoporos Int; 2013 Oct; 24(10):2591-601. PubMed ID: 23589163
    [Abstract] [Full Text] [Related]

  • 4. Effects of Two Years of Teriparatide, Denosumab, or Both on Bone Microarchitecture and Strength (DATA-HRpQCT study).
    Tsai JN, Uihlein AV, Burnett-Bowie SM, Neer RM, Derrico NP, Lee H, Bouxsein ML, Leder BZ.
    J Clin Endocrinol Metab; 2016 May; 101(5):2023-30. PubMed ID: 26964731
    [Abstract] [Full Text] [Related]

  • 5. Teriparatide increases strength of the peripheral skeleton in premenopausal women with idiopathic osteoporosis: a pilot HR-pQCT study.
    Nishiyama KK, Cohen A, Young P, Wang J, Lappe JM, Guo XE, Dempster DW, Recker RR, Shane E.
    J Clin Endocrinol Metab; 2014 Jul; 99(7):2418-25. PubMed ID: 24684466
    [Abstract] [Full Text] [Related]

  • 6. Differing effects of PTH 1-34, PTH 1-84, and zoledronic acid on bone microarchitecture and estimated strength in postmenopausal women with osteoporosis: an 18-month open-labeled observational study using HR-pQCT.
    Hansen S, Hauge EM, Beck Jensen JE, Brixen K.
    J Bone Miner Res; 2013 Apr; 28(4):736-45. PubMed ID: 23044908
    [Abstract] [Full Text] [Related]

  • 7. Comparative effects of teriparatide, denosumab, and combination therapy on peripheral compartmental bone density, microarchitecture, and estimated strength: the DATA-HRpQCT Study.
    Tsai JN, Uihlein AV, Burnett-Bowie SA, Neer RM, Zhu Y, Derrico N, Lee H, Bouxsein ML, Leder BZ.
    J Bone Miner Res; 2015 Jan; 30(1):39-45. PubMed ID: 25043459
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of Denosumab and Teriparatide Transitions on Bone Microarchitecture and Estimated Strength: the DATA-Switch HR-pQCT study.
    Tsai JN, Nishiyama KK, Lin D, Yuan A, Lee H, Bouxsein ML, Leder BZ.
    J Bone Miner Res; 2017 Oct; 32(10):2001-2009. PubMed ID: 28608571
    [Abstract] [Full Text] [Related]

  • 10. Effects of Combination Denosumab and High-Dose Teriparatide Administration on Bone Microarchitecture and Estimated Strength: The DATA-HD HR-pQCT Study.
    Ramchand SK, David NL, Lee H, Bruce M, Bouxsein ML, Leder BZ, Tsai JN.
    J Bone Miner Res; 2021 Jan; 36(1):41-51. PubMed ID: 32790196
    [Abstract] [Full Text] [Related]

  • 11. Effects of strontium ranelate and alendronate on bone microstructure in women with osteoporosis. Results of a 2-year study.
    Rizzoli R, Chapurlat RD, Laroche JM, Krieg MA, Thomas T, Frieling I, Boutroy S, Laib A, Bock O, Felsenberg D.
    Osteoporos Int; 2012 Jan; 23(1):305-15. PubMed ID: 21909729
    [Abstract] [Full Text] [Related]

  • 12. The Effect of Zoledronic Acid on Bone Microarchitecture and Strength after Denosumab and Teriparatide Administration: DATA-HD Study Extension.
    Ramchand SK, David NL, Lee H, Bruce M, Bouxsein ML, Tsai JN, Leder BZ.
    J Bone Miner Res; 2023 Jan; 38(1):26-34. PubMed ID: 36333954
    [Abstract] [Full Text] [Related]

  • 13. Accuracy of trabecular structure by HR-pQCT compared to gold standard μCT in the radius and tibia of patients with osteoporosis and long-term bisphosphonate therapy.
    Krause M, Museyko O, Breer S, Wulff B, Duckstein C, Vettorazzi E, Glueer C, Püschel K, Engelke K, Amling M.
    Osteoporos Int; 2014 May; 25(5):1595-606. PubMed ID: 24566588
    [Abstract] [Full Text] [Related]

  • 14. Teriparatide treatment exerts differential effects on the central and peripheral skeleton: results from the MOAT study.
    Paggiosi MA, Yang L, Blackwell D, Walsh JS, McCloskey E, Peel N, Eastell R.
    Osteoporos Int; 2018 Jun; 29(6):1367-1378. PubMed ID: 29520607
    [Abstract] [Full Text] [Related]

  • 15. Effects of odanacatib on the radius and tibia of postmenopausal women: improvements in bone geometry, microarchitecture, and estimated bone strength.
    Cheung AM, Majumdar S, Brixen K, Chapurlat R, Fuerst T, Engelke K, Dardzinski B, Cabal A, Verbruggen N, Ather S, Rosenberg E, de Papp AE.
    J Bone Miner Res; 2014 Aug; 29(8):1786-94. PubMed ID: 24643905
    [Abstract] [Full Text] [Related]

  • 16. Teriparatide Followed by Denosumab in Premenopausal Idiopathic Osteoporosis: Bone Microstructure and Strength by HR-pQCT.
    Agarwal S, Shiau S, Kamanda-Kosseh M, Bucovsky M, Kil N, Lappe JM, Stubby J, Recker RR, Guo XE, Shane E, Cohen A.
    J Bone Miner Res; 2023 Jan; 38(1):35-47. PubMed ID: 36335582
    [Abstract] [Full Text] [Related]

  • 17. Assessing the Effects of Teriparatide Treatment on Bone Mineral Density, Bone Microarchitecture, and Bone Strength.
    Kleerekoper M, Greenspan SL, Lewiecki EM, Miller PD, Kendler DL, Maricic M, Keaveny TM, Kopperdahl DL, Ruff VA, Wan X, Janos B, Krohn K.
    J Bone Joint Surg Am; 2014 Jun 04; 96(11):e90. PubMed ID: 24897747
    [Abstract] [Full Text] [Related]

  • 18. Comparative effects of teriparatide and ibandronate on spine bone mineral density (BMD) and microarchitecture (TBS) in postmenopausal women with osteoporosis: a 2-year open-label study.
    Senn C, Günther B, Popp AW, Perrelet R, Hans D, Lippuner K.
    Osteoporos Int; 2014 Jul 04; 25(7):1945-51. PubMed ID: 24760244
    [Abstract] [Full Text] [Related]

  • 19. Effect of oral monthly ibandronate on bone microarchitecture in women with osteopenia-a randomized placebo-controlled trial.
    Chapurlat RD, Laroche M, Thomas T, Rouanet S, Delmas PD, de Vernejoul MC.
    Osteoporos Int; 2013 Jan 04; 24(1):311-20. PubMed ID: 22402673
    [Abstract] [Full Text] [Related]

  • 20. A longitudinal HR-pQCT study of alendronate treatment in postmenopausal women with low bone density: Relations among density, cortical and trabecular microarchitecture, biomechanics, and bone turnover.
    Burghardt AJ, Kazakia GJ, Sode M, de Papp AE, Link TM, Majumdar S.
    J Bone Miner Res; 2010 Dec 04; 25(12):2558-71. PubMed ID: 20564242
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.